Roche’s combo lymphoma treatment wins U.S. FDA approval

The U.S. Food and Drug Administration on Monday granted earlier-than-expected approval to Roche Holding AG’s antibody-drug conjugate Polivy for treatment of patients with advanced lymphoma.

Original source: http://feeds.reuters.com/~r/reuters/INhealth/~3/SR7xuAlsfr8/roches-combo-lymphoma-treatment-wins-u-s-fda-approval-idINKCN1TB25S

Related Posts